Alliancebernstein L.P. Cuts Stock Holdings in Quanterix Co. (NASDAQ:QTRX)

Alliancebernstein L.P. lowered its position in Quanterix Co. (NASDAQ:QTRX - Free Report) by 25.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,439,805 shares of the company's stock after selling 825,798 shares during the period. Alliancebernstein L.P. owned about 6.33% of Quanterix worth $25,935,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of QTRX. Vanguard Group Inc. raised its holdings in Quanterix by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company's stock worth $23,569,000 after purchasing an additional 19,386 shares during the period. William Blair Investment Management LLC purchased a new position in shares of Quanterix during the 4th quarter valued at approximately $11,290,000. Easterly Investment Partners LLC grew its stake in Quanterix by 9.0% in the 4th quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company's stock valued at $10,152,000 after acquiring an additional 78,862 shares during the period. Geode Capital Management LLC increased its holdings in Quanterix by 2.2% in the 3rd quarter. Geode Capital Management LLC now owns 858,667 shares of the company's stock worth $11,131,000 after acquiring an additional 18,231 shares in the last quarter. Finally, State Street Corp raised its position in Quanterix by 2.2% during the third quarter. State Street Corp now owns 836,443 shares of the company's stock worth $10,840,000 after acquiring an additional 18,050 shares during the period. 86.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on QTRX shares. Scotiabank reissued an "outperform" rating on shares of Quanterix in a research note on Tuesday, March 25th. Canaccord Genuity Group reduced their target price on Quanterix from $20.00 to $15.00 and set a "buy" rating for the company in a report on Tuesday, March 18th.

Quanterix Stock Up 8.1 %

Shares of QTRX traded up $0.39 during midday trading on Friday, reaching $5.20. The company had a trading volume of 748,964 shares, compared to its average volume of 538,598. The stock has a market cap of $201.64 million, a PE ratio of -4.91 and a beta of 1.35. Quanterix Co. has a 1-year low of $4.67 and a 1-year high of $19.71. The firm has a 50 day simple moving average of $7.09 and a 200-day simple moving average of $10.01.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The firm had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.93 million. As a group, sell-side analysts anticipate that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.